The Roots Analysis team is putting in its best effort to offer our clients / readers a reliable source of information, regarding how the pharmaceutical and biotech sectors are coping in the midst of the COVID-19 pandemic. Our intention is to generate realistic insights, based on a variety of factors, which are anticipated to influence both prevalent and future market dynamics. Reach out to us for any help.

Isolator based Aseptic Filling Systems Market, 2020-2030

  • Lowest Price Guaranteed From USD 4,899

  • Published
    October 2020

  • Pages
    170

  • View Count
    588

Example Insights

Isolator-based-Aseptic-Filling-Systems-Market-Context 	Isolator-based-Aseptic-Filling-Systems-Market-List-of-Aspectic-Filling-Systems Isolator-based-Aseptic-Filling-Systems-Market-Geographical-Landscape
Isolator-based-Aseptic-Filling-Systems-Market-Competitiveness-Analysis Isolator-based-Aseptic-Filling-Systems-Market-Partnerships-and-Callaborations 	Isolator-based-Aseptic-Filling-Systems-Market-Future-Growth
Isolator-based-Aseptic-Filling-Systems-Market-Distribution    

 

Overview

Fill / finish is considered a critical aspect of pharmaceutical manufacturing. It is, therefore, imperative for drug manufacturers to ensure that formulations enclosed in primary containers are safe for consumption / administration. Despite being well established, there are several concerns associated with the contemporary drug filling process, such as the risk of contamination, filling errors (inaccurate dose dispensation), and labelling-related issues. In fact, experts in the industry believe that around 80% of product recalls may be attributed to packaging-related concerns.  Contamination is one of the key concerns related to fill / finish operations. To ensure the safety of consumers, a lot of effort is put into maintaining an aseptic environment during the fill / finish step. In this regard, manual intervention in filling lines is not only a threat to product safety (being more susceptible to contamination from contact with laborers), but also inefficient. Over the years, the growing complexity of modern pharmaceuticals (especially biologic drugs and complex small molecule APIs), has created a corresponding need for the automation of routine, repetitive tasks, such as fill / finish. As a result, the drug filling process is gradually becoming more demanding, in terms of specialized equipment and infrastructure, and handling expertise. 

Over the past couple of decades, pharma equipment manufacturers have developed more efficient, reliable and cost-effective machinery, involving the required isolators and restricted access barrier systems (RABS), to their proprietary filling lines. Many of such systems are designed to eliminate the need for human intervention, thereby, addressing the risk of operator-associated contamination. In addition, the use of filling lines where parts of the equipment are individually isolated, has been associated with notable cost saving opportunities. In such cases, developers need not invest in large, high-end cleanrooms for housing such filling lines. Currently, over 130 isolator-based filling and closing systems are available in the market, and equipment developers are still engaged in further improvement efforts.Given that more than 5,000 biopharmaceutical product candidates are currently under development, the opportunity for aseptic fill / finish equipment developers is anticipated to continue to grow at a substantial pace over the next decade.

Scope of the Report

The ‘Isolator based Aseptic Filling Systems Market, 2020-2030’ report features an extensive study of the current landscape of isolator based aseptic filling systems and the future opportunities associated with such systems. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the report features:

  • A detailed assessment of the overall landscape of the isolator based aseptic filling systems, highlighting the contribution of industry players and providing information on various types of systems (filling, and turnkey solutions), scale of operation (clinical and commercial), system throughput, compatible primary containers (ampoules, bottles, capsules, cartridges, syringes, vials and others), type of formulation and range of fill volume.
  • An insightful competitiveness analysis of isolator based aseptic filling systems, taking into consideration the scale of operation, system throughput, compatible primary containers, type of formulation and other important product related specifications.
  • Elaborate profiles of companies offering isolator based aseptic filling systems. Each profile features a brief overview of the company, its financial information (if available), proprietary product(s), recent developments and an informed future outlook.
  • A discussion on general regulatory guidelines for aseptic processing, and specific recommendations related to isolator and blow / fill / seal technologies used in the aseptic fill / finish process.
  • An analysis of various developments / recent trends related to aseptic processing market, offering insights on [A] partnerships and collaborations established within the industry, and [B] conferences held in this space.

One of the key objectives of the report was to understand the primary growth drivers and estimate the future opportunity within the market. Based on several parameters, such as annual fill / finish pharma capacity, number of automatic filling lines installed and growth trends across various geographies, we have provided an informed estimate of the likely evolution of the market, in the mid to long term, for the period 2020-2030. The chapter features the likely distribution of the opportunity across [A] scale of operation (clinical and commercial), [B] type of compatible primary container (ampoules, bottles, capsules, cartridges, syringes, vials and others), [C] system throughput (low throughput, medium throughput and high throughput), [D] end-user (pharmaceutical companies, contract service providers and others) and [E] geographical regions (North America, Europe, Asia-Pacific and rest of the world). In order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, portraying the conservative, base and optimistic tracks of the market’s evolution. 

The opinions and insights presented in this study were influenced by discussions conducted with stakeholders in this domain. 

All actual figures have been sourced and analyzed from publicly available information forums. Financial figures mentioned in this report are in USD, unless otherwise specified.

Contents

Chapter Outlines

Chapter 2 is an executive summary of the insights captured in our research. It offers a high-level view on the likely evolution of the aseptic filling systems market in the mid to long term.

Chapter 3 provides an overview of drug fill / finish process, and various aseptic fill / finish techniques. It also highlights the need for aseptic fill / finish in drug manufacturing, and various traditional and advanced aseptic fill / finish techniques currently being used in the pharma industry. Further, the chapter highlights a comparison between isolator and RABS systems, as well as various advantages associated with the advanced aseptic fill / finish methods and its future perspectives.

Chapter 4 provides an overview of the overall landscape of the isolator based aseptic filling systems, highlighting the contribution of industry players and providing information on various types of systems (filling, and turnkey solutions), scale of operation (clinical and commercial), system throughput, compatible primary containers (ampoules, bottles, capsules, cartridges, syringes, vials and others), type of formulation and range of fill volume.

Chapter 5 provides a detailed insightful competitiveness analysis of isolator based aseptic filling systems, taking into consideration the scale of operation, system throughput, compatible primary containers, type of formulation and other important product related specifications.

Chapter 6 includes detailed profiles of the companies offering isolator based aseptic filling systems. Each profile features a brief overview of the company, its financial information (if available), proprietary product(s), recent developments and an informed future outlook.

Chapter 7 providers general regulatory guidelines for aseptic processing, and specific recommendations related to isolator and blow / fill / seal technologies used in the aseptic fill / finish process.

Chapter 8 provides an analysis of various developments / recent trends related to aseptic processing market, offering insights on [A] partnerships and collaborations established within the industry, and [B] conferences held in this space.

Chapter 9 presents a detailed market forecast, highlighting the distribution of the opportunity across [A] scale of operation (clinical and commercial), [B] type of compatible primary container (ampoules, bottles, capsules, cartridges, syringes, vials and others), [C] system throughput (low throughput, medium throughput and high throughput), [D] end-user (pharmaceutical companies, contract service providers and others) and [E] geographical regions (North America, Europe, Asia-Pacific and rest of the world). 

Chapter 10 summarizes the entire report. It presents a list of key takeaways and offers our independent opinion on the current market scenario. Further, it summarizes the various evolutionary trends that are likely to influence the future of this market.

Chapter 11 is a collection of executive insight(s) of the discussion(s) that were held with key stakeholder(s) in this market. 

Chapter 12 is an appendix, which provides tabulated data and numbers for all the figures included in the report.

Chapter 13 is an appendix, which contains the list of companies and organizations mentioned in the report.

Table Of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of Drug Fill / Finish Processes

3.3. Aseptic Fill / Finish Technique
3.4. Need for Aseptic Fill / Finish 
3.5. Traditional Aseptic Fill / Finish Processes
3.6. Advanced Aseptic Fill / Finish Processes: Blow-Fill-Seal Aseptic 
 Technology
3.6.1. Isolator Systems
3.6.2. Restricted Access Barrier Systems (RABS)
3.6.3. Comparison between Isolator Systems and RABS
3.7. Advantages of Advanced Aseptic Fill / Finish Techniques
3.8. Regulatory Guidelines for Aseptic Fill / Finish 
3.9. Future Perspectives

4. ISOLATOR BASED ASEPTIC FILLING SYSTEMS: 
 CURRENT MARKET LANDSCAPE

4.1. Chapter Overview
4.2. Isolator based Aseptic Filling Systems: Overall Market Overview
4.2.1. Analysis by Type of System

4.2.2. Analysis by Scale of Operation
4.2.4. Analysis by System Throughput
4.2.5 Analysis by Compatible Primary Container(s)
4.2.6. Analysis by Type of Formulation
4.2.7. Analysis by Fill Volume Range

4.3. Isolator based Aseptic Filling Systems: Developer Landscape
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters
4.3.4. Leading Players: Analysis by Number of Proprietary Systems

5. ISOLATOR BASED ASEPTIC FILLING AND CLOSING SYSTEMS: PRODUCT COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Methodology and Key Parameters
5.3. Product Competitiveness Analysis: Peer Group I
5.4. Product Competitiveness Analysis: Peer Group II
5.5. Product Competitiveness Analysis: Peer Group III

6. COMPANY PROFILES
6.1. AST
6.1.1. Company Overview
6.1.2. Recent Developments and Future Outlook

6.2. Bausch+Ströbel
6.2.1. Company Overview
6.2.2. Recent Developments and Future Outlook

6.3. Dara Pharmaceutical Packaging
6.3.1. Company Overview
6.3.2. Recent Developments and Future Outlook

6.4. Groninger
6.4.1. Company Overview
6.4.2. Recent Developments and Future Outlook

6.5. IMA Group
6.5.1. Company Overview
6.5.2. Recent Developments and Future Outlook

6.6. Marchesini Group
6.6.1. Company Overview
6.6.2. Recent Developments and Future Outlook

6.7. OPTIMA Packaging Group
6.7.1. Company Overview
6.7.2. Recent Developments and Future Outlook

6.8. Syntegon 
6.8.1. Company Overview
6.8.2. Recent Developments and Future Outlook

6.9. Tofflon Group
6.9.1. Company Overview
6.9.2. Recent Developments and Future Outlook

6.10. Vanrx Pharmasystems
6.10.1. Company Overview
6.10.2. Recent Developments and Future Outlook

7. RECENT DEVELOPMENTS
7.1. Chapter Overview
7.2. Partnership Models
7.3. Isolator based Aseptic Filling Systems Market: Partnership Activity
7.3.1. List of Partnerships and Collaborations
7.3.2.1. Analysis by Year of Partnership
7.3.2.2. Analysis by Type of Partnership
7.3.2.3. Analysis by Focus Area
7.3.2.4. Most Active Players: Analysis by Number of Partnerships

7.4. Isolator based Aseptic Filling Systems Market: Recent Conferences
7.4.1. List of Recent Conferences
7.4.1.1. Analysis by Year of Occurrence
7.4.1.2. Analysis by Geography

7.4. Concluding Remarks

8. REGULATORY GUIDELINES: ASEPTIC PROCESSING
8.1. Chapter Overview
8.2. Overview of Cleanroom Grades
8.3. General Guidelines for Aseptic Processing
8.3.1. Requirements for Buildings and Facilities
8.3.2. Requirements for Personnel Training, Qualification and Monitoring
8.3.3. Requirements for Components and Containers / Closures

8.4. Guidelines for Using Isolator Technology
8.5. Guidelines for Using Blow / Fill / Seal Technology

9. MARKET FORECAST

9.1. Chapter Overview
9.2. Forecast Methodology and Key Assumptions
9.3. Overall Isolator based Aseptic Filling Systems Market, 2020-2030
9.4. Overall Isolator based Aseptic Filling Systems Market: Distribution by Scale of Operation, 2020-2030
9.5. Overall Isolator based Aseptic Filling Systems Market: Distribution by Type of Compatible Primary Container, 2020-2030
9.6. Overall Isolator based Aseptic Filling Systems Market: Distribution by System Throughput, 2020-2030 
9.7. Overall Isolator based Aseptic Filling Systems Market: Distribution by End-User, 2020-2030
9.8. Overall Isolator based Aseptic Filling Systems Market in North America, 2020-2030
9.8.1. Isolator based Aseptic Filling Systems Market in North America: Distribution by Scale of Operation, 2020-2030
9.8.1.1 Isolator based Aseptic Filling Systems Market in North America: Share of Clinical Scale Systems, 2020-2030
9.8.1.2. Isolator based Aseptic Filling Systems Market in North America: Share of Commercial Scale Systems, 2020-2030
9.8.2. Isolator based Aseptic Filling Systems Market in North America: Distribution by Type of Compatible Primary Container, 2020-2030
9.8.2.1 Isolator based Aseptic Filling Systems Market in North America: Share of Ampoules, 2020-2030
9.8.2.2 Isolator based Aseptic Filling Systems Market in North America: Share of Bottles, 2020-2030
9.8.2.3. Isolator based Aseptic Filling Systems Market in North America: Share of Capsules, 2020-2030
9.8.2.4. Isolator based Aseptic Filling Systems Market in North America: Share of Cartridges, 2020-2030
9.8.2.5. Isolator based Aseptic Filling Systems Market in North America: Share of Syringes, 2020-2030
9.8.2.6. Isolator based Aseptic Filling Systems Market in North America: Share of Vials, 2020-2030
9.8.2.7. Isolator based Aseptic Filling Systems Market in North America: Share of Other Primary Containers, 2020-2030
9.8.3. Isolator based Aseptic Filling Systems Market in North America: Distribution by System Throughput, 2020-2030
9.8.3.1. Isolator based Aseptic Filling Systems Market in North America: Share of Low Throughput Systems, 2020-2030
9.8.3.2. Isolator based Aseptic Filling Systems Market in North America: Share of Medium Throughput Systems, 2020-2030
9.8.3.4. Isolator based Aseptic Filling Systems Market in North America: Share of High Throughput Systems, 2020-2030
9.8.4. Isolator based Aseptic Filling Systems Market in North America: Distribution by End-User, 2020-2030
9.8.4.1 Isolator based Aseptic Filling Systems Market in North America: Share of Contract Service Providers, 2020-2030
9.8.4.2 Isolator based Aseptic Filling Systems Market in North America: Share of Pharmaceutical Companies, 2020-2030
9.8.4.3 Other End-Users, 2020-2030Isolator based Aseptic Filling Systems Market in North America: Share of Other End-Users, 2020-2030
9.9. Overall Isolator based Aseptic Filling Systems Market in Europe, 2020-2030
9.9.1. Isolator based Aseptic Filling Systems Market in Europe: Distribution by Scale of Operation, 2020-2030
9.9.1.1 Isolator based Aseptic Filling Systems Market in Europe: Share of Clinical Scale Systems, 2020-2030
9.9.1.2. Isolator based Aseptic Filling Systems Market in Europe: Share of Commercial Scale Systems, 2020-2030
9.9.2. Isolator based Aseptic Filling Systems Market in Europe: Distribution by Type of Compatible Primary Container, 2020-2030
9.9.2.1 Isolator based Aseptic Filling Systems Market in Europe: Share of Ampoules, 2020-2030
9.9.2.2 Isolator based Aseptic Filling Systems Market in Europe: Share of Bottles, 2020-2030
9.9.2.3 Isolator based Aseptic Filling Systems Market in Europe: Share of Capsules, 2020-2030
9.9.2.4 Isolator based Aseptic Filling Systems Market in Europe: Share of Cartridges, 2020-2030
9.9.2.5 Isolator based Aseptic Filling Systems Market in Europe: Share of Syringes, 2020-2030
9.9.2.6 Isolator based Aseptic Filling Systems Market in Europe: Share of Vials, 2020-2030
9.9.2.7 Isolator based Aseptic Filling Systems Market in Europe: Share of Other Primary Containers, 2020-2030
9.9.3. Isolator based Aseptic Filling Systems Market in Europe: Distribution by System Throughput, 2020-2030
9.9.3.1 Isolator based Aseptic Filling Systems Market in Europe: Share of Low Throughput Systems, 2020-2030
9.9.3.2 Isolator based Aseptic Filling Systems Market in Europe: Share of Medium Throughput Systems, 2020-2030
9.9.3.3. Isolator based Aseptic Filling Systems Market in Europe: Share of High Throughput Systems, 2020-2030
9.9.4. Isolator based Aseptic Filling Systems Market in Europe: Distribution by End-User, 2020-2030
9.9.4.1 Isolator based Aseptic Filling Systems Market in Europe: Share of Contract Service Providers, 2020-2030
9.9.4.2 Isolator based Aseptic Filling Systems Market in Europe: Share of Pharmaceutical Companies, 2020-2030
9.9.4.3 Isolator based Aseptic Filling Systems Market in Europe: Share of Other End-Users, 2020-2030
9.10. Overall Isolator based Aseptic Filling Systems Market in Asia-Pacific, 2020-2030
9.10.1. Isolator based Aseptic Filling Systems Market in Asia-Pacific: Distribution by Scale of Operation, 2020-2030
9.10.1.1 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Clinical Scale Systems, 2020-2030
9.10.1.2. Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Commercial Scale Systems, 2020-2030
9.10.2. Isolator based Aseptic Filling Systems Market in Asia-Pacific: Distribution by Type of Compatible Primary Container, 2020-2030
9.10.2.1 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Ampoules, 2020-2030
9.10.2.2 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Bottles, 2020-2030
9.10.2.3 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Capsules, 2020-2030
9.10.2.4 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Cartridges, 2020-2030
9.10.2.5 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Syringes, 2020-2030
9.10.2.6 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Vials, 2020-2030
9.10.2.7 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Other Primary Containers, 2020-2030
9.10.3. Isolator based Aseptic Filling Systems Market in Asia-Pacific: Distribution by System Throughput, 2020-2030
9.10.3.1 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Low Throughput Systems, 2020-2030
9.10.3.2 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Medium Throughput Systems, 2020-2030
9.10.3.3 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of High Throughput Systems, 2020-2030
9.10.4. Isolator based Aseptic Filling Systems Market in Asia-Pacific: Distribution by End-User, 2020-2030
9.10.4.1 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Contract Service Providers, 2020-2030
9.10.4.2 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Pharmaceutical Companies, 2020-2030
9.10.4.3 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Other End-Users, 2020-2030
9.11. Overall Isolator based Aseptic Filling Systems Market in Rest of the World, 2020-2030
9.11.1. Isolator based Aseptic Filling Systems Market in Rest of the World: Distribution by Scale of Operation, 2020-2030
9.11.1.1 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Clinical Scale Systems, 2020-2030
9.11.1.2. Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Commercial Scale Systems, 2020-2030
9.11.2. Isolator based Aseptic Filling Systems Market in Rest of the World: Distribution by Type of Compatible Primary Container, 2020-2030
9.11.2.1 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Ampoules, 2020-2030
9.11.2.2 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Bottles, 2020-2030
9.11.2.3 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Capsules, 2020-2030
9.11.2.4 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Cartridges, 2020-2030
9.11.2.5 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Syringes, 2020-2030
9.11.2.6 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Vials, 2020-2030
9.11.2.7 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Other Primary Containers, 2020-2030
9.11.3. Isolator based Aseptic Filling Systems Market in Rest of the World: Distribution by System Throughput, 2020-2030
9.11.3.1 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Low Throughput Systems, 2020-2030
9.11.3.2 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Medium Throughput Systems, 2020-2030
9.11.3.3 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of High Throughput Systems, 2020-2030
9.11.4. Isolator based Aseptic Filling Systems Market in Rest of the World: Distribution by End-User, 2020-2030
9.11.4.1 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Contract Service Providers, 2020-2030
9.11.4.2 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Pharmaceutical Companies, 2020-2030
9.11.4.3 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Other End-Users, 2020-2030

10. CONCLUSION
10.1. Chapter Overview
10.2. Key Takeaways

11. EXECUTIVE INSIGHTS
11.1. Chapter Overview
11.2. Automated Systems of Tacoma (AST)
11.2.1. Interview Transcript: Joe Hoff, Chairman and CEO
12. APPENDIX 1: TABULATED DATA

13. APPENDIX 2: LIST OF COMPANIES AND ORGANISATIONS

List Of Figures

Figure 3.1 Drug Fill / Finish Process
Figure 3.2 Aseptic Fill / Finish Workflow
Figure 3.3 Comparison of Traditional Filling with Blow / Fill / Seal Technologies
Figure 3.4 Aseptic Processing Equipment and Degrees of Sterility
Figure 3.5 Comparison of RABS with Isolators
Figure 4.1 Isolator based Aseptic Filling Systems: Distribution by Type of System
Figure 4.2 Isolator based Aseptic Filling Systems: Distribution by Scale of Operation
Figure 4.3 Isolator based Aseptic Filling Systems: Distribution by System Throughput
Figure 4.4 Isolator based Aseptic Filling Systems: Distribution by Compatible Primary Container(s)
Figure 4.5 Grid Map Analysis by System Throughput and Compatible Primary Container
Figure 4.6 Isolator based Aseptic Filling Systems: Distribution by Type of Formulation
Figure 4.7 Isolator based Aseptic Filling Systems: Distribution by Fill Volume Range
Figure 4.8 Isolator based Aseptic Filling System Providers: Distribution by Year of Establishment
Figure 4.9 Isolator based Aseptic Filling System Providers: Distribution by Company Size
Figure 4.10 Logo Landscape of System Developers: Distribution by Company Size
Figure 4.11 Isolator based Aseptic Filling System Providers: Distribution by Geography
Figure 4.12 Leading Players: Distribution by Number of Proprietary Systems
Figure 5.1 Competitiveness Analysis: Products in Peer Group I
Figure 5.2 Competitiveness Analysis: Products in Peer Group II
Figure 5.3 Competitiveness Analysis: Products in Peer Group III
Figure 7.1 Partnerships and Collaborations: Distribution by Year of Partnership
Figure 7.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 7.3 Partnerships and Collaborations: Distribution by Focus Area
Figure 7.4 Most Active Players: Distribution by Number of Partnerships
Figure 7.5 Recent Conferences: Distribution by Year of Occurrence
Figure 7.6 Recent Conferences: Distribution by Geographical Location
Figure 8.1 Airborne Particulate Classification for Different Cleanroom Grades
Figure 9.1 Overall Isolator based Aseptic Filling Systems Market (USD Million), 2020-2030
Figure 9.2 Overall Isolator based Aseptic Filling Systems Market: Distribution by Scale of Operation (USD Million), 2020-2030
Figure 9.3 Overall Isolator based Aseptic Filling Systems Market: Distribution by Type of Compatible Primary Container (USD Million), 2020-2030
Figure 9.4 Overall Isolator based Aseptic Filling Systems Market: Distribution by System Throughput (USD Million), 2020-2030
Figure 9.5 Overall Isolator based Aseptic Filling Systems Market: Distribution by End- User (USD Million), 2020-2030
Figure 9.6 Isolator based Aseptic Filling Systems Market in North America: Share of Clinical Scale Systems (USD Million), 2020-2030
Figure 9.7 Isolator based Aseptic Filling Systems Market in North America: Share of Commercial Scale Systems (USD Million), 2020-2030
Figure 9.8 Isolator based Aseptic Filling Systems Market in North America: Share of Ampoules (USD Million), 2020-2030
Figure 9.9 Isolator based Aseptic Filling Systems Market in North America: Share of Bottles (USD Million), 2020-2030
Figure 9.10 Isolator based Aseptic Filling Systems Market in North America: Share of Capsules (USD Million), 2020-2030
Figure 9.11 Isolator based Aseptic Filling Systems Market in North America: Share of Cartridges (USD Million), 2020-2030
Figure 9.12 Isolator based Aseptic Filling Systems Market in North America: Share of Syringes (USD Million), 2020-2030
Figure 9.13 Isolator based Aseptic Filling Systems Market in North America: Share of Vials (USD Million), 2020-2030
Figure 9.14 Isolator based Aseptic Filling Systems Market in North America: Share of Other Primary Containers (USD Million), 2020-2030
Figure 9.15 Isolator based Aseptic Filling Systems Market in North America: Share of Low Throughput Systems (USD Million), 2020-2030
Figure 9.16 Isolator based Aseptic Filling Systems Market in North America: Share of Medium Throughput Systems (USD Million), 2020-2030
Figure 9.17 Isolator based Aseptic Filling Systems Market in North America: Share of High Throughput Systems (USD Million), 2020-2030
Figure 9.18 Isolator based Aseptic Filling Systems Market in North America: Share of Contract Service Providers (USD Million), 2020-2030
Figure 9.19 Isolator based Aseptic Filling Systems Market in North America: Share of Pharmaceutical Companies (USD Million), 2020-2030
Figure 9.20 Isolator based Aseptic Filling Systems Market in Europe: Share of Other End-Users (USD Million), 2020-2030
Figure 9.21 Isolator based Aseptic Filling Systems Market in Europe: Share of Clinical Scale Systems (USD Million), 2020-2030
Figure 9.22 Isolator based Aseptic Filling Systems Market in Europe: Share of Commercial Scale Systems (USD Million), 2020-2030
Figure 9.23 Isolator based Aseptic Filling Systems Market in Europe: Share of Ampoules (USD Million), 2020-2030
Figure 9.24 Isolator based Aseptic Filling Systems Market in Europe: Share of Bottles (USD Million), 2020-2030
Figure 9.25 Isolator based Aseptic Filling Systems Market in Europe: Share of Capsules (USD Million), 2020-2030
Figure 9.26 Isolator based Aseptic Filling Systems Market in Europe: Share of Cartridges (USD Million), 2020-2030
Figure 9.27 Isolator based Aseptic Filling Systems Market in Europe: Share of Syringes, (USD Million), 2020-2030
Figure 9.28 Isolator based Aseptic Filling Systems Market in Europe: Share of Vials, (USD Million), 2020-2030
Figure 9.29 Isolator based Aseptic Filling Systems Market in Europe: Share of Other Primary Containers (USD Million), 2020-2030
Figure 9.30 Isolator based Aseptic Filling Systems Market in Europe: Share of Low Throughput Systems (USD Million), 2020-2030
Figure 9.31 Isolator based Aseptic Filling Systems Market in Europe: Share of Medium Throughput Systems (USD Million), 2020-2030
Figure 9.32 Isolator based Aseptic Filling Systems Market in Europe: Share of High Throughput Systems (USD Million), 2020-2030
Figure 9.33 Isolator based Aseptic Filling Systems Market in Europe: Share of Contract Service Providers (USD Million), 2020-2030
Figure 9.34 Isolator based Aseptic Filling Systems Market in Europe: Share of Pharmaceutical Companies (USD Million), 2020-2030
Figure 9.35 Isolator based Aseptic Filling Systems Market in Europe: Share of Other End-Users (USD Million), 2020-2030
Figure 9.36 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Clinical Scale Systems (USD Million), 2020-2030
Figure 9.37 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Commercial Scale Systems (USD Million), 2020-2030
Figure 9.38 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Ampoules (USD Million), 2020-2030
Figure 9.39 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Bottles (USD Million), 2020-2030
Figure 9.40 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Capsules (USD Million), 2020-2030
Figure 9.41 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Cartridges (USD Million), 2020-2030
Figure 9.42 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Syringes (USD Million), 2020-2030
Figure 9.43 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Vials (USD Million), 2020-2030
Figure 9.44 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Other Primary Containers (USD Million), 2020-2030
Figure 9.45 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Low Throughput Systems (USD Million), 2020-2030
Figure 9.46 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Medium Throughput Systems (USD Million), 2020-2030
Figure 9.47 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of High Throughput Systems (USD Million), 2020-2030
Figure 9.48 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Contract Service Providers (USD Million), 2020-2030
Figure 9.49 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Pharmaceutical Companies (USD Million), 2020-2030
Figure 9.50 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Other End-Users (USD Million), 2020-2030
Figure 9.51 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Clinical Scale Systems (USD Million), 2020-2030
Figure 9.52 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Commercial Scale Systems (USD Million), 2020-2030
Figure 9.53 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Ampoules (USD Million), 2020-2030
Figure 9.54 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Bottles (USD Million), 2020-2030
Figure 9.55 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Capsules (USD Million), 2020-2030
Figure 9.56 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Cartridges (USD Million), 2020-2030
Figure 9.57 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Syringes (USD Million), 2020-2030
Figure 9.58 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Vials (USD Million), 2020-2030
Figure 9.59 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Other Primary Containers (USD Million), 2020-2030
Figure 9.60 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Low Throughput Systems (USD Million), 2020-2030
Figure 9.61 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Medium Throughput Systems (USD Million), 2020-2030
Figure 9.62 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of High Throughput Systems (USD Million), 2020-2030
Figure 9.63 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Contract Service Providers (USD Million), 2020-2030
Figure 9.64 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Pharmaceutical Companies (USD Million), 2020-2030
Figure 9.65 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Other End-Users (USD Million), 2020-2030

List Of Tables

Table 4.1 Isolator based Aseptic Filling Systems: Information on Developer, Type of System and Scale of Operation
Table 4.2 Isolator based Aseptic Filling Systems: Information on System Throughput
Table 5.3 Isolator based Aseptic Filling Systems: Information on Compatible Primary Container(s)
Table 5.4 Isolator based Aseptic Filling Systems: Information on the Type of Formulation
Table 4.5 List of Companies Providing Isolator based Aseptic Filling Systems
Table 6.1 AST: Company Snapshot
Table 6.2 AST: Recent Developments and Future Outlook
Table 6.3 Bausch+Ströbel: Company Snapshot
Table 6.4 Bausch+Ströbel: Recent Developments and Future Outlook
Table 6.5 Dara Pharmaceutical Packaging: Company Snapshot
Table 6.6 Dara Pharmaceutical Packaging: Recent Developments and Future Outlook
Table 6.7 Groninger: Company Snapshot
Table 6.8 Groninger: Recent Developments and Future Outlook
Table 6.9 IMA Group: Company Snapshot
Table 6.10 IMA Group: Recent Developments and Future Outlook
Table 6.11 Marchesini Group: Company Snapshot
Table 6.12 Marchesini Group: Recent Developments and Future Outlook
Table 6.13 OPTIMA Packaging Group: Company Snapshot
Table 6.14 OPTIMA Packaging Group: Recent Developments and Future Outlook
Table 6.15 Syntegon: Company Snapshot
Table 6.16 Syntegon: Recent Developments and Future Outlook
Table 6.17 Tofflon Group: Company Snapshot
Table 6.18 Tofflon Group: Recent Developments and Future Outlook
Table 6.19 Vanrx Pharmasystems: Company Snapshot
Table 6.20 Vanrx Pharmasystems: Recent Developments and Future Outlook
Table 7.1 Isolator based Aseptic Filling Systems: List of Partnerships and Collaborations, 2017-2020
Table 7.2 Isolator based Aseptic Filling Systems: List of Conferences, 2017-2020
Table 12.1 Isolator based Aseptic Filling Systems: Distribution by Type of System
Table 12.2 Isolator based Aseptic Filling Systems: Distribution by Scale of Operation
Table 12.3 Isolator based Aseptic Filling Systems: Distribution by System Throughput
Table 12.4 Isolator based Aseptic Filling Systems: Distribution by Compatible Primary Container(s)
Table 12.5 Isolator based Aseptic Filling Systems: Distribution by Type of Formulation
Table 12.6 Isolator based Aseptic Filling Systems: Distribution by Fill Volume Range
Table 12.8 Isolator based Aseptic Filling System Providers: Distribution by Year of Establishment
Table 12.9 Isolator based Aseptic Filling System Providers: Distribution by Company Size
Table 12.10 Isolator based Aseptic Filling System Providers: Distribution by Geography
Table 12.11 Isolator based Aseptic Filling Systems Market Partnership Activity: Analysis by Year of Partnership
Table 12.12 Isolator based Aseptic Filling Systems Market Partnership Activity: Analysis by Type of Partnership
Table 12.14 Isolator based Aseptic Filling Systems Market Partnership: Analysis by Number of Partnerships
Table 12.15 Isolator based Aseptic Filling Systems Market Recent Conferences: Analysis by Year of Occurrence
Table 12.16 Isolator based Aseptic Filling Systems Market Recent Conferences: Analysis by Geographical Location
Table 12.17 Overall Isolator based Aseptic Filling Systems Market (USD Million), 2020-2030
Table 12.18 Overall Isolator based Aseptic Filling Systems Market: Distribution by Scale of Operation (USD Million), 2020-2030
Table 12.19 Overall Isolator based Aseptic Filling Systems Market: Distribution by Type of Compatible Primary Container (USD Million), 2020-2030
Table 12.20 Overall Isolator based Aseptic Filling Systems Market: Distribution by System Throughput (USD Million), 2020-2030
Table 12.21 Overall Isolator based Aseptic Filling Systems Market: Distribution by End- User (USD Million), 2020-2030
Table 12.22 Isolator based Aseptic Filling Systems Market in North America: Share of Clinical Scale Systems (USD Million), 2020-2030
Table 12.23 Isolator based Aseptic Filling Systems Market in North America: Share of Commercial Scale Systems (USD Million), 2020-2030
Table 12.24 Isolator based Aseptic Filling Systems Market in North America: Share of Ampoules (USD Million), 2020-2030
Table 12.25 Isolator based Aseptic Filling Systems Market in North America: Share of Bottles (USD Million), 2020-2030
Table 12.26 Isolator based Aseptic Filling Systems Market in North America: Share of Capsules (USD Million), 2020-2030
Table 12.27 Isolator based Aseptic Filling Systems Market in North America: Share of Cartridges (USD Million), 2020-2030
Table 12.28 Isolator based Aseptic Filling Systems Market in North America: Share of Syringes (USD Million), 2020-2030
Table 12.29 Isolator based Aseptic Filling Systems Market in North America: Share of Vials (USD Million), 2020-2030
Table 12.30 Isolator based Aseptic Filling Systems Market in North America: Share of Other Primary Containers (USD Million), 2020-2030
Table 12.31 Isolator based Aseptic Filling Systems Market in North America: Share of Low Throughput Systems (USD Million), 2020-2030
Table 12.32 Isolator based Aseptic Filling Systems Market in North America: Share of Medium Throughput Systems (USD Million), 2020-2030
Table 12.33 Isolator based Aseptic Filling Systems Market in North America: Share of High Throughput Systems (USD Million), 2020-2030
Table 12.34 Isolator based Aseptic Filling Systems Market in North America: Share of Contract Service Providers (USD Million), 2020-2030
Table 12.35 Isolator based Aseptic Filling Systems Market in North America: Share of Pharmaceutical Companies (USD Million), 2020-2030
Table 12.36 Isolator based Aseptic Filling Systems Market in Europe: Share of Clinical Other End-Users (USD Million), 2020-2030
Table 12.37 Isolator based Aseptic Filling Systems Market in Europe: Share of Clinical Scale Systems (USD Million), 2020-2030
Table 12.38 Isolator based Aseptic Filling Systems Market in Europe: Share of Commercial Scale Systems (USD Million), 2020-2030
Table 12.39 Isolator based Aseptic Filling Systems Market in Europe: Share of Ampoules (USD Million), 2020-2030
Table 12.40 Isolator based Aseptic Filling Systems Market in Europe: Share of Bottles (USD Million), 2020-2030
Table 12.41 Isolator based Aseptic Filling Systems Market in Europe: Share of Capsules (USD Million), 2020-2030
Table 12.42 Isolator based Aseptic Filling Systems Market in Europe: Share of Cartridges (USD Million), 2020-2030
Table 12.43 Isolator based Aseptic Filling Systems Market in Europe: Share of Syringes (USD Million), 2020-2030
Table 12.44 Isolator based Aseptic Filling Systems Market in Europe: Share of Vials (USD Million), 2020-2030
Table 12.45 Isolator based Aseptic Filling Systems Market in Europe: Share of Other Primary Containers (USD Million), 2020-2030
Table 12.46 Isolator based Aseptic Filling Systems Market in Europe: Share of Low Throughput Systems (USD Million), 2020-2030
Table 12.47 Isolator based Aseptic Filling Systems Market in Europe: Share of Medium Throughput Systems (USD Million), 2020-2030
Table 12.48 Isolator based Aseptic Filling Systems Market in Europe: Share of High Throughput Systems (USD Million), 2020-2030
Table 12.49 Isolator based Aseptic Filling Systems Market in Europe: Share of Contract Service Providers (USD Million), 2020-2030
Table 12.50 Isolator based Aseptic Filling Systems Market in Europe: Share of Pharmaceutical Companies (USD Million), 2020-2030
Table 12.51 Isolator based Aseptic Filling Systems Market in Europe: Share of Other End-Users (USD Million), 2020-2030
Table 12.52 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Clinical Scale Systems (USD Million), 2020-2030
Table 12.53 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Commercial Scale Systems (USD Million), 2020-2030
Table 12.54 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Ampoules (USD Million), 2020-2030
Table 12.55 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Bottles (USD Million), 2020-2030
Table 12.56 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Capsules (USD Million), 2020-2030
Table 12.57 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Cartridges, 2020-2030
Table 12.58 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Syringes (USD Million), 2020-2030
Table 12.59 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Vials (USD Million), 2020-2030
Table 12.60 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Other Primary Containers (USD Million), 2020-2030
Table 12.61 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Low Throughput Systems (USD Million), 2020-2030
Table 12.62 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Medium Throughput Systems (USD Million), 2020-2030
Table 12.63 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of High Throughput Systems (USD Million), 2020-2030
Table 12.64 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Contract Service Providers (USD Million), 2020-2030
Table 12.65 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Pharmaceutical Companies (USD Million), 2020-2030
Table 12.66 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Other End-Users (USD Million), 2020-2030
Table 12.67 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Clinical Scale Systems (USD Million), 2020-2030
Table 12.68 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Commercial Scale Systems (USD Million), 2020-2030
Table 12.69 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Ampoules (USD Million), 2020-2030
Table 12.70 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Bottles (USD Million), 2020-2030
Table 12.71 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Capsules (USD Million), 2020-2030
Table 12.72 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Cartridges (USD Million), 2020-2030
Table 12.73 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Syringes (USD Million), 2020-2030
Table 12.74 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Vials (USD Million), 2020-2030
Table 12.75 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Other Primary Containers (USD Million), 2020-2030
Table 12.76 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Low Throughput Systems (USD Million), 2020-2030
Table 12.77 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Medium Throughput Systems (USD Million), 2020-2030
Table 12.78 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of High Throughput Systems (USD Million), 2020-2030
Table 12.79 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Contract Service Providers (USD Million), 2020-2030
Table 12.80 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Pharmaceutical Companies (USD Million), 2020-2030
Table 12.81 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Other End-Users (USD Million), 2020-2030

List Of Company

The following companies and organizations have been mentioned in the report.

  1. ACG
  2. ACIC Pharmaceutical Machinery
  3. Advaxis
  4. Aflex Hose
  5. Ambica Pharma Machines
  6. Anchor Mark
  7. Antares Vision
  8. ARaymondlife
  9. Argonaut Manufacturing Services
  10. Aseptic Technologies
  11. Auteco Sistemi
  12. Automated Systems of Tacoma (AST)
  13. AWS Bio-Pharma Technologies
  14. AXOMATIC
  15. BAUSCH Advanced Technology Group
  16. Bausch+Ströbel
  17. Bosch Packaging Technology
  18. Carlo Corazza 
  19. Catalent
  20. Charles Thompson
  21. CMP PHAR.MA 
  22. Comecer
  23. COOLVACUUM Technologies
  24. CPi Technology
  25. Creinox
  26. CVC Capital Partners
  27. Daikyo Seiko 
  28. Dara Pharma
  29. Extract Technology
  30. FUJIFILM Diosynth Biotechnologies 
  31. G-CON Manufacturing 
  32. GEA Group
  33. Getinge
  34. gmp-experts Beratungs
  35. groninger
  36. Harro Höfliger
  37. i-Dositecno
  38. IMA Group
  39. Inno4Life
  40. Klenzaids
  41. LG Life Sciences
  42. Libbs Farmaceutica 
  43. M&O Perry Industries
  44. Maier Packaging
  45. Marchesini Group
  46. Martin Christ Freeze Dryers 
  47. Massachusetts Institute of Technology
  48. MEDInstill
  49. Netsteril
  50. NJM Packaging
  51. Nova Laboratories
  52. OPTIMA
  53. PennTech Machinery 
  54. Pfizer
  55. Pharmaceutics International (Pii) 
  56. Quality Machines
  57. Romaco
  58. ROTA
  59. säntis Packaging
  60. Schematic Engineering Industries
  61. Schmucker 
  62. SCHOTT KAISHA
  63. SEA Vision
  64. Shanghai Divine Medical Technology
  65. Shanghai Jianzhong Medical Packaging
  66. Shibuya 
  67. Shilpa Medicare 
  68. Shree Bhagwati Machtech 
  69. Singota Solutions
  70. SKAN
  71. Snowbell Machines
  72. SP Scientific
  73. SPIMACO
  74. Steriline
  75. Stevanato Group
  76. Syntegon
  77. TELSTAR
  78. Terra Asia Consulting
  79. Thai Industrial Pharmacist Association (TIPA)
  80. Tofflon
  81. TRUKING TECHNOLOGY
  82. Vanrx Pharmasystems
  83. Vibrotech
  84. VITRONIC Machine Vision
  85. Watson-Marlow Fluid Technology Group 
  86. Wipf

Request Customization

Please select a suitable option for customization in the report

PRICING DETAILS

USD 4,899

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site / office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm / enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com